• FirefoxInstall the new Firefox »
  •  Dow Down 0.15% Nasdaq Down 0.18%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    26.07 Down 0.93(3.44%) 12:54PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:27.00
    Open:27.54
    Bid:26.34 x 100
    Ask:26.37 x 100
    1y Target Est:26.67
    Beta:-0.38
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:25.65 - 28.85
    52wk Range:19.10 - 61.44
    Volume:468,018
    Avg Vol (3m):694,416
    Market Cap:741.30M
    P/E (ttm):N/A
    EPS (ttm):-1.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEGR

    Comparison

    Symbol% ChgMkt Cap
    AEGRDown 3.44%741.30M
    AZNUp 0.04%87.20B
    MRKDown 0.26%167.65B
    PFEDown 0.40%217.06B

    Key Statistics

    Forward P/E (1 yr):56.11
    P/S (ttm):5.85
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.19
    Quarterly EPS Est (Mar-15) :-0.08
    Mean Recommendation*:2.9
    PEG Ratio (5 yr expected):-27.86

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback